Overview
Sunil Hingorani is an Oncologist practicing medicine in Seattle, Washington.
Dr. Hingorani is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer and Pancreatic Ductal Adenocarcinoma.
He is actively involved in clinical research, co-authoring 54 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- POS
Locations
825 Eastlake Ave E, Seattle, WA 98109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Rachel Loschiavo PA-C
Ajay Gopal is an Oncologist practicing medicine in Seattle, Washington. Dr. Gopal is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Follicular Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, and Classical Hodgkin Lymphoma.
Swedish Cardiovascular RSRCH
John Pagel is an Oncologist practicing medicine in Seattle, Washington. Dr. Pagel is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Rachel Loschiavo PA-C
Petros Grivas is an Oncologist practicing medicine in Seattle, Washington. Dr. Grivas is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Endoscopy.
Frequently Asked Questions about Dr. Sunil Hingorani
How do I make an appointment with Dr. Sunil Hingorani?
You can book an appointment with Dr. Sunil Hingorani by calling their office at 206-288-1000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Sunil Hingorani a top-rated expert for Pancreatic Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sunil Hingorani is classified as an Distinguished expert for Pancreatic Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Sunil Hingorani specialize in?
While Dr. Sunil Hingorani is a Oncology, they have specific expertise in Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Sunil Hingorani participate in research or clinical trials?
Yes. Dr. Sunil Hingorani has published 54 articles and abstracts on conditions like Pancreatic Cancer. You can view a list of Dr. Sunil Hingorani's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Sunil Hingorani accept my insurance?
Dr. Sunil Hingorani accepts most major insurance plans, including Medica and Oscar. We recommend calling the office directly at 206-288-1000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Pancreatic CancerDr. Hingorani isDistinguished. Learn about Pancreatic Cancer.
- Pancreatic Ductal AdenocarcinomaDr. Hingorani isDistinguished. Learn about Pancreatic Ductal Adenocarcinoma.